Gut Microbial Metabolites and Future Risk of Parkinson’s Disease: A Metabolome-wide Association Study
Objective: To prospectively investigate the association between plasma microbial metabolites and Parkinson’s disease (PD) risk within a metabolomics framework. Background: Gut microbiota is altered in…Functionality Analysis of Immunoregulatory Cells Stimulated with Dopaminergic Agonists in People Living with Parkinson’s Disease
Objective: To evaluate the effect of dopaminergic agonists (DA) on the activation and functionality of regulatory cells in People living with Parkinson's Disease (PwP). Background:…Higher Putamen Volume Asymmetry with Age-Preserved Volume in Isolated Adult-Onset Cervical Dystonia
Objective: This study aims to explore the relationship between left and right putamen volumes in cervical dystonia (CD) patients compared to age-matched healthy controls (HC),…A group of patients with multiple system atrophy (MSA) exhibit cardiac sympathetic dysfunction to the same extent as Parkinson’s disease (PD).
Objective: Although there are cases of multiple system atrophy (MSA) with decreased MIBG, there has not been sufficient investigation into the proportion. Thus, we retrospectively…Analysis of structural connectivity in relation to change in dopaminergic medication after 6 months of STN-DBS in Parkinson´s disease – a pilot study
Objective: To describe the relationship between structural connectivity and it´s effect on change in levodopa equivalent daily dose (LEDD) in patients 6 months after subthalamic…Abnormal basal ganglia-related functional gradient in Parkinson’s disease
Objective: The aim of this research was to investigate the basal ganglia (BG)-related functional gradient alterations and the association between these brain dysfunctions and clinical…Impact of Altered Cerebrovascular Reactivity on Midbrain Degeneration, Perfusion and White Matter
Objective: To evaluate whether altered cerebrovascular reactivity contributes to midbrain degeneration, perfusion abnormalities, or white matter disease in patients with Parkinson’s disease (PD). Background: Cerebrovascular…Improved Quantification of DAT-SPECT significantly increases its Performance as an Imaging Biomarker in Parkinson’s Disease
Objective: To investigate potential improvements in signal-to-noise (SNR) derived from advanced image analysis of longitudinal DAT-SPECT data. Background: [123I]Ioflupane SPECT (DAT-SPECT) has been widely used…Transcranial Sonography of the Substantia Nigra and Vagus Nerve Ultrasonography as Complementary Diagnosis for Parkinson’s Disease.
Objective: We aim to investigate the relationship between sonographic abnormalities of the substantia nigra, vagus nerve cross-sectional area and clinical features of PD in different…Early changes in the locus coeruleus in mild cognitive impairment with Lewy bodies
Objective: To evaluate NMS signal changes in the locus coeruleus (LC) in mild cognitive impairment with Lewy bodies (MCI-LB) as compared to healthy controls (HC)…
- « Previous Page
- 1
- …
- 100
- 101
- 102
- 103
- 104
- …
- 181
- Next Page »